Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Anticonvulsant activity of Benkara malabarica (Linn.) root extract: In vitro and in vivo investigation.

Authors: Mishra, N  Oraon, A  Dev, A  Jayaprakash, V  Basu, A  Pattnaik, AK  Tripapthi, SN  Akhtar, M  Ahmad, S  Swaroop, S  Basu, M 
Citation: Mishra N, etal., J Ethnopharmacol. 2010 Mar 24;128(2):533-6. doi: 10.1016/j.jep.2010.01.042. Epub 2010 Jan 28.
Pubmed: (View Article at PubMed) PMID:20109543
DOI: Full-text: DOI:10.1016/j.jep.2010.01.042

AIM OF THE STUDY: To systematically investigate the anticonvulsant activity of methanol extract of Benkara malabarica roots and to provide a biochemical basis elucidating its mode of action. METHODS: The median lethal dose (LD(50)) of Benkara malabarica extract was determined. The anticonvulsant activity of the extract was assessed in strychnine-induced and isoniazide-induced convulsion models; phenytoin (20mg/kg) and diazepam (1mg/kg) were used as standards, respectively. Percentage protection provided by the drug was accounted as decrease in the number of convulsions within 8h of observation. Mechanism of action was studied by performing GABA transaminase (GABA-T) assay, isolated from rat brain. Active constituent was isolated and characterized from the plant extract. RESULTS: The median lethal dose (LD50) of Benkara malabarica was found to be more than 500 mg/kg. It demonstrated 30% and 35% protection against strychnine-induced convulsions and 60% and 80% protection against isoniazide-induced convulsions, at doses of 25mg/kg and 50mg/kg, respectively. Enzyme assay results revealed that Benkara malabarica extract possesses GABA-T inhibitory activity (IC50=0.721 mg/ml). Scopoletin which was identified as the major constituent of the extract was found to be an inhibitor of GABA-T (IC50=10.57 microM). CONCLUSIONS: The anticonvulsant activity of the plant extract is predominantly GABA mediated and may be due to the action of scopoletin alone or is a result of synergy of different compounds in the extract in which scopoletin is the major constituent.


Disease Annotations
Objects Annotated

Additional Information

CRRD Object Information
CRRD ID: 9588535
Created: 2014-10-30
Species: All species
Last Modified: 2014-10-30
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.